The Greg Marzolf Jr. Muscular Dystrophy Center

Proud to partner in advancing care for the LGMD community 💙
This investment supports expanded access, stronger care coordination, and innovative models to better serve patients at the University of Minnesota.

🚀 A major step forward for the limb-girdle muscular dystrophy (LGMD) community is here! The Muscular Dystrophy Association and BridgeBio are partnering on a $100,000 investment to strengthen multidisciplinary care for people living with LGMD at leading MDA Care Centers at Stanford Health Care and the University of Minnesota.

These innovative projects will help expand access to care, strengthen coordination across specialties, and support hybrid care models that meet patients where they are. 🩺✨

🔗Read the full story: https://www.mda.org/press-releases/mda-announces-100000-investment-to-advance-lgmd-care-at-leading-mda-care-centers-with-bridgebio

We’re excited to share that we are a founding LGMD Center of Excellence, with Dr. Peter Kang serving in clinical leadership as part of this patient‑led national network.

The Speak Foundation Launches Patient-Led National LGMD Centers of Excellence, Uniting Leading Academic Institutions to Accelerate Clinical Trials and New Therapies Limb-Girdle Muscular Dystrophy Centers of Excellence Launching to Accelerate Clinical Trials and New Therapies

RSVP by February 9th: https://z.umn.edu/mdcenter-labday2026
February 21st, please join us for the annual MD Center Lab Day. Come learn about the muscle research happening at the University of Minnesota.

2026 MD Center Lab Day Registration Lab Day Open House: Muscle Research at the University of Minnesota When: Saturday, February 21st, 2026 Time: 10:30am - 1pm Where: Cancer & Cardiovascular Research Building 2231 6th St. SE, Minneapolis, MN 55455

Remember to RSVP by February 10th!

RSVP by February 9th: https://z.umn.edu/mdcenter-labday2026
February 21st, please join us for the annual MD Center Lab Day. Come learn about the muscle research happening at the University of Minnesota.

Sign up to receive updates on community events, patient outreach activities, and our newsletter.

mcphzdmd56g8qjv0xcx4wnrpgccm.pub.sfmc-content.com

RSVP by February 9th: https://z.umn.edu/mdcenter-labday2026
February 21st, please join us for the annual MD Center Lab Day. Come learn about the muscle research happening at the University of Minnesota.

It's GivingTuesday!
Join the global movement of generosity and make a difference in our community. https://z.umn.edu/mdcenter-donate

MD Center faculty, Dr. Darko Bosnakovski and Dr. Michael Kyba, found a potential new therapeutic approach to protect and repair muscles in FSHD. Certain enzymes called MMPs, are overactive in FSHD, worsening muscle damage. When these enzymes are inactivated, FSHD mice have reduced inflammation and scarring.

JCI Insight - Matrix metalloproteinases are hallmark early biomarkers and therapeutic targets in FSHD Address correspondence to: Darko Bosnakovski, Cancer & Cardiovascular Research Building, 2231 6th St. SE, Minneapolis, Minnesota 55455, USA. Phone: 651.206.2183; Email: [email protected].

The Greg Marzolf Jr. Muscular Dystrophy Center at the University of Minnesota, has a new clinical trial for Duchenne Muscular Dystrophy (DMD). Contact [email protected] for any questions.
https://studyfinder.umn.edu/studies/32060?fbclid=IwY2xjawNmBK9leHRuA2FlbQIxMQABHuwZIS2-_5Icgqp5vh7VtMmqlE74KG7vxhreEvBqveZ3N_13oeRHNaQepnvt_aem_c61z_g4mdfYF6hekd_eVNQ

Phase I Clinical Trial of iPSC-Based Therapy (MyoPAXon) for Duchenne Muscular Dystrophy Learn more about this study with StudyFinder!